United States · Markets & Finance · Investor's Business Daily

AbbVie Partner Flies Sky-High On News For Its $3 Billion Cancer Contender

Published by Investor's Business Daily · United States 12 h ago

The addition of Genmab's Epkinly to a standard cocktail of drugs helped lymphoma patients live longer before worsening.

MediaNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (www.investors.com)

Also worth reading